Atrial fibrillation (AF) is an important risk factor for ischemic stroke resulting in a fivefold
increased stroke risk and a twofold increased mortality. Our understanding of stroke …

Although the benefit of antithrombotic therapy for stroke prevention in atrial fibrillation (AF) is
well recognized, its potential effect on stroke severity and outcome is less well established …

more strokes than elderly men, when matched for other risk factors, and this is not accounted
for by transesophageal echocardiographic markers of stasis. It is unclear whether sustained …

Background—Strokes in patients with atrial fibrillation (AF) are typically larger, are
associated with higher early mortality, and occur in older patients versus strokes in patients …

Background and Purpose—The best time for administering anticoagulation therapy in acute
cardioembolic stroke remains unclear. This prospective cohort study of patients with acute …

Introduction Stroke is one of the leading causes of mortality and morbidity globally. Atrial
fibrillation (AF) is the most common sustained cardiac arrhythmia. It is set to reach epidemic …

AFDAS may differ from atrial fibrillation known before stroke in several clinical dimensions,
which are important for optimal patient care strategies. Many questions remain unanswered …

Rationale Atrial fibrillation causes one-fifth of ischemic strokes, with a high risk of early
recurrence. Although long-term anticoagulation is highly effective for stroke prevention in …

Anticoagulation substantially reduces the risk of stroke in patients with atrial fibrillation (AF).
However, recent studies have shown that up to 22%–36% of patients on anticoagulation will …

Background Atrial fibrillation (AF) is a common arrhythmia and a major risk factor for stroke.
Many physicians remain reluctant to provide stroke prevention by anticoagulant therapy …